International Journal of Nanomedicine · 2012 · 48 citations · 30 references
PharmacyOncologyPharmacologyDrug DeliveryMolecular OncologyNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineMagnetic NanomaterialsNanomaterials For Drug DeliveryNanomedicinePancreatic CancerFerrite NanoparticlesIron Oxide NanoparticlesMagnetic Drug Delivery SystemsMagnetic Nanoparticle Drug CarriersMagnetic Nanoparticle Drug DeliveryMagnetic NanoparticlesMagnetic Oxide NanoparticlesVascular Endothelial Growth Factor
BACKGROUND: E26 transformation-specific sequence-1 (ETS1) transcription factor plays important roles in both carcinogenesis and the progression of a wide range of malignancies. Aberrant ETS1 expression correlates with aggressive tumor behavior and a poorer prognosis in patients with various malignancies. The aim of the current study was to evaluate the efficacy of a drug delivery system utilizing gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles (GA-MNP-Fe(3)O(4)) on the suppression of ETS1-mediated cell proliferation and migration in Panc-1 pancreatic cancer cells. METHODS: The effects caused by GA-MNP-Fe(3)O(4) on the proliferation of Panc-1 pancreatic cancer cells were evaluated using a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay while inhibition of tumor cell migration was investigated in a scratch assay. The expressions of ETS1, cyclin D1, urokinase-type plasminogen activator (u-PA), and VEGF (vascular endothelial growth factor) were examined by Western blot to elucidate the possible mechanisms involved. RESULTS: In Panc-1 pancreatic cancer cells, we observed that application of GA-MNP-Fe(3)O(4) was able to suppress cancer cell proliferation and prevent cells from migrating effectively. After treatment, Panc-1 pancreatic cancer cells showed significantly decreased expression of ETS1, as well as its downstream target genes for cyclin D1, u-PA, and VEGF. CONCLUSION: Our novel finding reaffirmed the significance of ETS1 in the treatment of pancreatic cancer, and application of GA-MNP-Fe(3)O(4) nanoparticles targeting ETS1 should be considered as a promising contribution for better pancreatic cancer care.
30
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
A strategy for ZnO nanorod mediated multi-mode cancer treatment
Haijun Zhang, Baoan Chen, Hui Jiang et al. · Biomaterials · 2010 · 320 citations
Pharmacy, Cancer Biology, Oncology +12